Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer

Published:2019-01-28 Issue:10 Volume:26 Page:2100-2114
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Ramakrishnan Swathi,Granger Victoria,Rak Monika,Hu Qiang,Attwood Kristopher,Aquila Lanni,Krishnan Nithya,Osiecki Rafal,Azabdaftari Gissou,Guru Khurshid,Chatta Gurkamal,Gueron Geraldine^ORCID,McNally Lacey,Ohm Joyce,Wang Jianmin,Woloszynska Anna

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-019-0278-9.pdf

Reference64 articles.

1. Nargund AM, Pham CG, Dong Y, Wang PI, Osmangeyoglu HU, Xie Y, et al. The SWI/SNF protein PBRM1 restrains VHL-loss-driven clear cell renal cell carcinoma. Cell Rep. 2017;18:2893–906.

2. Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet. 2017;49:296–302.

3. Aldiri I, Ajioka I, Xu B, Zhang J, Chen X, Benavente C, et al. Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma. Development. 2015;142:4092–106.

4. Gao SB, Zheng QF, Xu B, Pan CB, Li KL, Zhao Y, et al. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma. Mol Cancer Res. 2014;12:1388–97.

5. Venkatesan N, Wong JF, Tan KP, Chung HH, Yau YH, Cukuroglu E, et al. EZH2 promotes neoplastic transformation through VAV interaction-dependent extranuclear mechanisms. Oncogene. 2018;37:461–77.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artemisinin pre-treatment fore cisplatin dosage enhances high grade urothelial carcinoma treatment in male albino mice via reverse gene expression modulation of FGFR3, HRAS, P53 and KDM6A;BMC Cancer;2024-08-08

2. KDM3A Ablation Activates Endogenous Retrovirus Expression to Stimulate Antitumor Immunity in Gastric Cancer;Advanced Science;2024-07-19

3. Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial;Cancer Medicine;2024-06

4. New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication;MedComm;2024-05-23

5. New clinical trial design in precision medicine: discovery, development and direction;Signal Transduction and Targeted Therapy;2024-03-04